ARS Pharmaceuticals, Inc. (SPRY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
3525 Del Mar Heights Road
San Diego, CA 92130
United States of America (the)
Phone
858 335 1300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
155
First IPO Date
December 04, 2020
| Name | Title | Pay | Year Born |
| Richard Lowenthal MSMSEL | Co-Founder, CEO & Director | 3.48M | 1966 |
| Eric Karas | Chief Commercial Officer | 618,614 | 1973 |
| Alexander A. Fitzpatrick | Chief Legal Officer & Secretary | 677,145 | 1967 |
| Justin Chakma | Chief Business Officer | 682,700 | 1990 |
| Brian T. Dorsey | Chief Operations Officer | 706,970 | 1969 |
| Sarina Tanimoto | Co-Founder & Chief Medical Officer | 3.18M | 1969 |
| Donn Casale | President | 0 | 1973 |
| Daniel Relovsky | Senior Vice President of Marketing | 0 | N/A |
| Kathleen D. Scott | Chief Financial Officer | 0 | N/A |
| Lynda Harris | Vice President of Human Resources | 0 | N/A |
| Robert Bell | Co-Founder & Chief Science Officer | 0 | N/A |
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.